A vitamin D-based strategy overcomes chemoresistance in prostate cancer.

Kateryna Len-TayonClaire BeraudClara FauveauAnna Y BelorusovaYassmine ChebaroAntonio MouriñoThierry MassfelderAnne ChauchereauDaniel MetzgerNatacha RochelGilles Laverny

Published in: British journal of pharmacology (2024)

Taken together, these results unravel the potency of VDR agonists to overcome chemoresistance in CRPC and open new avenues for the clinical management of PCa.

Keyphrases

prostate cancer
radical prostatectomy
minimally invasive
cancer stem cells